References
- Eichenwald , K. and Kolata , G. 1999 . Research for hire: A doctor's drug studies turn into fraud . New York Times , May 17
- Enserink , M. 2000 . Bioethics: Helsinki's new clinical rules: Fewer placebos, more disclosure . Science , 290 : 418
- FDA . 1997 . International Conference on Harmonization (ICH) Harmonised Tripartite Guideline for Good Clinical Practice. . Fed. Reg. , 62 May 9 : 25691 – 25709 .
- FDA, 21 CFR Part 50. Protection of Human Subjects
- FDA, 21 CFR Part 56. Institutional Review Boards
- FDA, 21 CFR Part 312. Investigational New Drug Application (IND)
- FDA, 21 CFR Part 314. Applications (and abbreviated applications) for FDA approval to market a new drug
- FDA, 21 CFR Part 54. Financial Disclosure
- Finn , R. 1999 . Cancer Clinical Trials: Experimental Treatments & How They Can Help You , O'Reilly & Assoc, Inc .
- HHS, Office of Inspector General (OIG) . 1998 . Institutional Review Boards: A Time for Reform , June
- HHS . 2000 . Standards for Privacy or Individually Identifiable Health Information, Final Rule 45 CFR Parts 160–164 . Federal Register , 65 December 28 : 82462 – 82829 .
- HHS, Office of Inspector General . 2000 . Protecting Human Research Subjects: Status of Recommendations , April
- Law , J. 1999 . The Changing Face of the CRO . Scrip Magazine , December : 46 – 48 .
- Malakoff , D. 2000 . Flawed cancer study leads to shake‐up at Univ. of Oklahoma . Science , 289 August 4 : 706 – 707 .
- National Bioethics Advisory Commission (NBAC) . 2001 . Ethical and Policy Issue in International Research , April
- OHRP . 2001 . Financial Relationships in Clinical Research: Issues for Institutions, Clinical Investigators, and IRBs to Consider when Dealing with Issues of Financial Interests and Human Subject Protection . Draft Interim Guidance , Jan.
- OIG . 2000 . Recruiting Human Subjects: Pressures in Industry‐Sponsored Clinical Research , June
- OIG . 2000 . Recruiting Human Subjects: Sample Guidelines for Practice , June
- OIG . 2000 . FDA Oversight of Clinical Investigators , June
- Winkler , G. and Marsh , R. 1996 . Creating a successful CRO‐sponsor relationship through alignment of goals and values . Drug Information Journal , 30 : 113 – 117 .
- Woolen , S. 2000 . Patient Misuse and Investigator Fraud in Clinical Trials: What Can Be Done? Part I . Power Point Slides , June 14 http://www.fda.gov/cder/present/ dia‐62000/wooleni/indexhtm (visited website January 17,2001)
- 2000 . OHRP halts human research at University of Oklahoma for subject protection violations . Guide to Good Clinical Practice , 7 ( 1 ) September : 4 – 5 .
- 2000 . Legal analysts examine unique state clinical research requirements . Guide to Good Clinical Practice , 12 September : 6 – 7 .
- The Business of Human Experiments: Ethical, Legal and Regulatory Issues, Third National Ethics Conference, Sponsored by Friends Research Institute, Inc. November 3–5, 2000.
- Corresponding author. Tel.: 919–998–2072. Fax: 919–998–2090. E‐mail: [email protected].